Abstract
Butyrate, a short-chain fatty acid (SCFA) produced by bacterial fermentation of fiber in the colon, is a source of energy for colonocytes. Butyrate is essential for improving gastrointestinal (GI) health since it helps colonocyte function, reduces inflammation, preserves the gut barrier, and fosters a balanced microbiome. Human colonic butyrate producers are Gram-positive firmicutes, which are phylogenetically varied. The two most prevalent subgroups are associated with Eubacterium rectale/Roseburia spp. and Faecalibacterium prausnitzii. Now, the mechanism for the production of butyrate from microbes is a very vital topic to know. In the present study, we discuss the genes encoding the core of the butyrate synthesis pathway and also discuss the butyryl-CoA:acetate CoA-transferase, instead of butyrate kinase, which usually appears to be the enzyme that completes the process. Recently, butyrate-producing microbes have been genetically modified by researchers to increase butyrate synthesis from microbes. The activity of butyrate as a histone deacetylase inhibitor (HDACi) has led to several clinical trials to assess its effectiveness as a potential cancer treatment. Among various significant roles, butyrate is the main energy source for intestinal epithelial cells, which helps maintain colonic homeostasis. Moreover, people with non-small-cell lung cancer (NSCLC) have distinct gut microbiota from healthy adults and frequently have dysbiosis of the butyrate-producing bacteria in their guts. So, with an emphasis on colon and lung cancer, this review also discusses how the microbiome is crucial in preventing the progression of certain cancers through butyrate production. Further studies should be performed to investigate the underlying mechanisms of how these specific butyrate-producing bacteria can control both colon and lung cancer progression and prognosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
No datasets were generated or analysed during the current study.
References
Alam S, Stevens D, Bajpai RK (2005) Production of butyric acid by batch fermentation of cheese whey with Clostridium beijerinckii. J Ind Microbiol 2:359–364
Al-Qadami GH, Secombe KR, Subramaniam CB, Wardill HR, Bowen JM (2022) Gut microbiota-derived short-chain fatty acids: impact on cancer treatment response and toxicities. Microorganisms 10(10):2048. https://doi.org/10.3390/microorganisms10102048
Aminov RI, Walker AW, Duncan SH, Harmsen HJ, Welling GW, Flint HJ (2006) Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol 72:6371–6376. https://doi.org/10.1128/aem.00701-06
Araki Y, Andoh A, Takizawa J, Takizawa W, Fujiyama Y (2004) Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int J Mol Med 13:577–580
Araújo JR, Tomas J, Brenner C, Sansonetti PJ (2017) Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity. Biochimie 141:97–106. https://doi.org/10.1016/j.biochi.2017.05.019
Baek J-M et al (2013) Butyrate production in engineered Escherichia coli with synthetic scaffolds. Biotechnol Bioeng 110:2790–2794. https://doi.org/10.1002/bit.24925
Baroi GN, Baumann I, Westermann P, Gavala HN (2015) Butyric acid fermentation from pretreated and hydrolysed wheat straw by an adapted Clostridium tyrobutyricum strain. Microb Biotechnol 8:874–882. https://doi.org/10.1111/1751-7915.12304
Bingham SA et al (2003) Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361:1496–1501. https://doi.org/10.1016/s0140-6736(03)13174-1
Bingula R et al (2018) Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: study protocol for case-control observational trial. Medicine (baltimore) 97:e13676. https://doi.org/10.1097/md.0000000000013676
Bordonaro M, Mariadason JM, Aslam F, Heerdt BG, Augenlicht LH (1999) Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Cell Growth Differ 10:713–720
Candido EP, Reeves R, Davie JR (1978) Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14:105–113. https://doi.org/10.1016/0092-8674(78)90305-7
Cani PD et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–1481. https://doi.org/10.2337/db07-1403
Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 111:2247–2252. https://doi.org/10.1073/pnas.1322269111
Chen J, Vitetta L (2018) Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin Colorectal Cancer 17:e541–e544. https://doi.org/10.1016/j.clcc.2018.05.001
Chen HM et al (2013) Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 97:1044–1052. https://doi.org/10.3945/ajcn.112.046607
Chen L, Zhou X, Wang Y, Wang D, Ke Y, Zeng X (2021) Propionate and butyrate produced by gut microbiota after probiotic supplementation attenuate lung metastasis of melanoma cells in mice. Mol Nutr Food Res 65:e2100096. https://doi.org/10.1002/mnfr.202100096
Chen H et al (2023) Global research trends between gut microbiota and lung cancer from 2011 to 2022: a bibliometric and visualization analysis. Front Oncol 13:1137576. https://doi.org/10.3389/fonc.2023.1137576
Clausen MR, Mortensen PB (1995) Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut 37:684–689. https://doi.org/10.1136/gut.37.5.684
Counillon L, Bouret Y, Marchiq I, Pouysségur J (2016) Na(+)/H(+) antiporter (NHE1) and lactate/H(+) symporters (MCTs) in pH homeostasis and cancer metabolism. Biochim Biophys Acta 1863:2465–2480. https://doi.org/10.1016/j.bbamcr.2016.02.018
Csordas A (1996) Butyrate, aspirin and colorectal cancer. Eur J Cancer Prev 5:221–231. https://doi.org/10.1097/00008469-199608000-00002
de Vos WM, de Vos EA (2012) Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev 70(Suppl 1):S45–S56. https://doi.org/10.1111/j.1753-4887.2012.00505.x
De Vuyst L, Moens F, Selak M, Rivière A, Leroy F (2014) Summer meeting 2013: growth and physiology of bifidobacteria. J Appl Microbiol 116:477–491. https://doi.org/10.1111/jam.12415
Desai MS et al (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167:1339–1353.e1321.https://doi.org/10.1016/j.cell.2016.10.043
Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB (2016) The microbiome and the respiratory tract. Annu Rev Physiol 78:481–504. https://doi.org/10.1146/annurev-physiol-021115-105238
Donohoe DR et al (2014) A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov 4:1387–1397. https://doi.org/10.1158/2159-8290.Cd-14-0501
Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73:1073–1078. https://doi.org/10.1128/aem.02340-06
Dwidar M, Park JY, Mitchell RJ, Sang BI (2012) The future of butyric acid in industry. ScientificWorldJournal 2012:471417. https://doi.org/10.1100/2012/471417
El Aidy S, Van den Abbeele P, Van de Wiele T, Louis P, Kleerebezem M (2013) Intestinal colonization: how key microbial players become established in this dynamic process: microbial metabolic activities and the interplay between the host and microbes. BioEssays 35:913–923. https://doi.org/10.1002/bies.201300073
Encarnação JC, Abrantes AM, Pires AS, Botelho MF (2015) Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Cancer Metastasis Rev 34:465–478. https://doi.org/10.1007/s10555-015-9578-9
Fleming SE, Fitch MD, Chansler MW (1989) High-fiber diets: influence on characteristics of cecal digesta including short-chain fatty acid concentrations and pH. Am J Clin Nutr 50:93–99. https://doi.org/10.1093/ajcn/50.1.93
Ghosh TS et al (2020) Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 69:1218–1228. https://doi.org/10.1136/gutjnl-2019-319654
Gnagnarella P, Caini S, Maisonneuve P, Gandini S (2018) Carcinogenicity of high consumption of meat and lung cancer risk among non-smokers: a comprehensive meta-analysis. Nutr Cancer 70:1–13. https://doi.org/10.1080/01635581.2017.1374420
Gui Q et al (2020) The association between gut butyrate-producing bacteria and non-small-cell lung cancer. J Clin Lab Anal 34:e23318. https://doi.org/10.1002/jcla.23318
Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F (2010) From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev 23:366–384. https://doi.org/10.1017/s0954422410000247
Gupta N, Martin PM, Prasad PD, Ganapathy V (2006) SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci 78:2419–2425. https://doi.org/10.1016/j.lfs.2005.10.028
Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ (2008) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27:104–119. https://doi.org/10.1111/j.1365-2036.2007.03562.x
Hodgkinson K et al (2023) Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal disease. Clin Nutr 42:61–75. https://doi.org/10.1016/j.clnu.2022.10.024
Hold GL, Schwiertz A, Aminov RI, Blaut M, Flint HJ (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69:4320–4324. https://doi.org/10.1128/aem.69.7.4320-4324.2003
Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268–1273. https://doi.org/10.1126/science.1223490
Hove H, Holtug K, Jeppesen PB, Mortensen PB (1995) Butyrate absorption and lactate secretion in ulcerative colitis. Dis Colon Rectum 38:519–525. https://doi.org/10.1007/bf02148853
Hu S, Kuwabara R, de Haan BJ, Smink AM, de Vos P (2020) Acetate and butyrate improve β-cell metabolism and mitochondrial respiration under oxidative stress. Int J Mol Sci 21(4):1542. https://doi.org/10.3390/ijms21041542
Huang J et al (2011) Efficient production of butyric acid from Jerusalem artichoke by immobilized Clostridium tyrobutyricum in a fibrous-bed bioreactor. Bioresour Technol 102:3923–3926. https://doi.org/10.1016/j.biortech.2010.11.112
Huerta-Yepez S, Tirado-Rodriguez A, Montecillo-Aguado MR, Yang J, Hammock BD, Hankinson O (2020) Aryl hydrocarbon receptor-dependent inductions of omega-3 and omega-6 polyunsaturated fatty acid metabolism act inversely on tumor progression. Sci Rep 10:7843. https://doi.org/10.1038/s41598-020-64146-6
Jiang L, Wang J, Liang S, Wang X, Cen P, Xu Z (2009) Butyric acid fermentation in a fibrous bed bioreactor with immobilized Clostridium tyrobutyricum from cane molasses. Bioresour Technol 100:3403–3409. https://doi.org/10.1016/j.biortech.2009.02.032
Karim MR et al (2023) A review on Impact of dietary interventions, drugs, and traditional herbal supplements on the gut microbiome. Microbiol Res 271:127346. https://doi.org/10.1016/j.micres.2023.127346
Kashtoh H, Baek KH (2022) Recent updates on phytoconstituent alpha-glucosidase inhibitors: an approach towards the treatment of type two diabetes. Plants (basel) 11(20):2722. https://doi.org/10.3390/plants11202722
Knudsen KE, Jensen BB, Hansen I (1993) Oat bran but not a beta-glucan-enriched oat fraction enhances butyrate production in the large intestine of pigs. J Nutr 123:1235–1247. https://doi.org/10.1093/jn/123.7.1235
Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165:1332–1345. https://doi.org/10.1016/j.cell.2016.05.041
Kong LY, Chen XY, Lu X, Caiyin Q, Yang DH (2023) Association of lung-intestinal microecology and lung cancer therapy. Chin Med 18:37. https://doi.org/10.1186/s13020-023-00742-8
Lai MJ, Lan EI (2019) Photoautotrophic synthesis of butyrate by metabolically engineered cyanobacteria. Biotechnol Bioeng 116:893–903. https://doi.org/10.1002/bit.26903
Lazarova DL, Bordonaro M, Carbone R, Sartorelli AC (2004) Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer 110:523–531. https://doi.org/10.1002/ijc.20152
Lazarova DL, Chiaro C, Bordonaro M (2014) Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells. BMC Res Notes 7:226. https://doi.org/10.1186/1756-0500-7-226
Le Chatelier E et al (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500:541–546. https://doi.org/10.1038/nature12506
Li M, van Esch B, Henricks PAJ, Folkerts G, Garssen J (2018) The Anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor α-stimulated endothelial cells via activation of GPR41/43 and inhibition of HDACs. Front Pharmacol 9:533. https://doi.org/10.3389/fphar.2018.00533
Liu H et al (2018) Butyrate: a double-edged sword for health? Adv Nutr 9:21–29. https://doi.org/10.1093/advances/nmx009
Liu X et al (2021) The role of gut microbiota in lung cancer: from carcinogenesis to immunotherapy. Front Oncol 11:720842. https://doi.org/10.3389/fonc.2021.720842
Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661–672. https://doi.org/10.1038/nrmicro3344
Ma N, Tian Y, Wu Y, Ma X (2017a) Contributions of the interaction between dietary protein and gut microbiota to intestinal health. Curr Protein Pept Sci 18:795–808. https://doi.org/10.2174/1389203718666170216153505
Ma N et al (2017b) Dimethyl fumarate reduces the risk of mycotoxins via improving intestinal barrier and microbiota. Oncotarget 8:44625–44638. https://doi.org/10.18632/oncotarget.17886
Ma J, Piao X, Mahfuz S, Long S, Wang J (2022) The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Anim Nutr 9:159–174. https://doi.org/10.1016/j.aninu.2021.09.012
Maczulak AE, Wolin MJ, Miller TL (1993) Amounts of viable anaerobes, methanogens, and bacterial fermentation products in feces of rats fed high-fiber or fiber-free diets. Appl Environ Microbiol 59:657–662. https://doi.org/10.1128/aem.59.3.657-662.1993
Matijašić BB, Rajšp MK, Perko B, Rogelj I (2007) Inhibition of Clostridium tyrobutyricum in cheese by Lactobacillus gasseri. Int Dairy J 17:157–166
Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107–118. https://doi.org/10.1016/j.cell.2005.05.007
McIntyre A, Gibson PR, Young GP (1993) Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386–391. https://doi.org/10.1136/gut.34.3.386
Miller TL, Wolin MJ (1979) Fermentations by saccharolytic intestinal bacteria1 2. Am J Clin Nutr 32:164–172. https://doi.org/10.1093/ajcn/32.1.164
Miquel S et al (2014) Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Gut Microbes 5:146–151. https://doi.org/10.4161/gmic.27651
Miyaki M et al (1999) Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59:4506–4509
Moore WE, Moore LH (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61:3202–3207. https://doi.org/10.1128/aem.61.9.3202-3207.1995
Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108:801–809. https://doi.org/10.1017/s0007114512001213
Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7:189–200. https://doi.org/10.1080/19490976.2015.1134082
Mukherjee A, Lordan C, Ross RP, Cotter PD (2020) Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes 12:1802866. https://doi.org/10.1080/19490976.2020.1802866
Nagasaka M, Sexton R, Alhasan R, Rahman S, Azmi AS, Sukari A (2020) Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—a review. Crit Rev Oncol Hematol 145:102841. https://doi.org/10.1016/j.critrevonc.2019.102841
Nakamoto N et al (2019) Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol 4:492–503. https://doi.org/10.1038/s41564-018-0333-1
Ni X, Li L, Pan G (2015) HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review). Oncol Lett 9:515–521. https://doi.org/10.3892/ol.2014.2714
Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T (2005) Oral administration of Butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 135:2878–2883. https://doi.org/10.1093/jn/135.12.2878
Oliver AL (2022) Lung cancer: epidemiology and screening. Surg Clin North Am 102:335–344. https://doi.org/10.1016/j.suc.2021.12.001
Peng L, Li ZR, Green RS, Holzman IR, Lin J (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139:1619–1625. https://doi.org/10.3945/jn.109.104638
Peters U et al (2003) Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361:1491–1495. https://doi.org/10.1016/s0140-6736(03)13173-x
Plata C, Gavi-Maza M, Vázquez N, Romero MF, Gamba G (2014) Aspirin and salicylate are solutes of both sodium monocarboxylate transporters (SMCT1/Slc5a8 and SMCT2/Slc5a12) (896.9). FASEB J 28
Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217:133–139. https://doi.org/10.1111/j.1574-6968.2002.tb11467.x
Ramey D, Yang ST (2005) Production of butyric acid and butanol from biomass. Final report to the US Department of Energy. Contract No.: DE-F-G02-00ER86106
Rath E, Haller D (2022) Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury. Mucosal Immunol 15:595–604. https://doi.org/10.1038/s41385-022-00514-x
Rebroš M, Dolejš I, Stloukal R, Rosenberg M (2016) Butyric acid production with Clostridium tyrobutyricum immobilised to PVA gel. Process Biochem 51:704–708. https://doi.org/10.1016/j.procbio.2016.03.003
Ritzhaupt A, Ellis A, Hosie KB, Shirazi-Beechey SP (1998) The characterization of butyrate transport across pig and human colonic luminal membrane. J Physiol 507(Pt 3):819–830. https://doi.org/10.1111/j.1469-7793.1998.819bs.x
Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L (2016) Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 7:979. https://doi.org/10.3389/fmicb.2016.00979
Sakamoto J, Nakaji S, Sugawara K, Iwane S, Munakata A (1996) Comparison of resistant starch with cellulose diet on 1,2-dimethylhydrazine-induced colonic carcinogenesis in rats. Gastroenterology 110:116–120. https://doi.org/10.1053/gast.1996.v110.pm8536846
Salvi PS, Cowles RA (2021) Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells 10(7):1775. https://doi.org/10.3390/cells10071775
Sanaei M, Kavoosi F (2019) Histone deacetylases and histone deacetylase inhibitors: molecular mechanisms of action in various cancers. Adv Biomed Res 8:63. https://doi.org/10.4103/abr.abr_142_19
Schug ZT, Vande Voorde J, Gottlieb E (2016) The metabolic fate of acetate in cancer. Nat Rev Cancer 16:708–717. https://doi.org/10.1038/nrc.2016.87
Shah DR, Masters GA (2020) Precision medicine in lung cancer treatment. Surg Oncol Clin N Am 29:15–21. https://doi.org/10.1016/j.soc.2019.08.002
Shah H, Ng TL (2023) A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome. Transl Lung Cancer Res 12:909–926. https://doi.org/10.21037/tlcr-22-595
Shi B et al (2020) Effect of sodium butyrate on ABC transporters in lung cancer A549 and colorectal cancer HCT116 cells. Oncol Lett 20:148. https://doi.org/10.3892/ol.2020.12011
Singh V et al (2014) Translating molecular physiology of intestinal transport into pharmacologic treatment of diarrhea: stimulation of Na+ absorption. Clin Gastroenterol Hepatol 12:27–31. https://doi.org/10.1016/j.cgh.2013.10.020
Smith JG, Yokoyama WH, German JB (1998) Butyric acid from the diet: actions at the level of gene expression. Crit Rev Food Sci Nutr 38:259–297. https://doi.org/10.1080/10408699891274200
Sommer F, Bäckhed F (2013) The gut microbiota–masters of host development and physiology. Nat Rev Microbiol 11:227–238. https://doi.org/10.1038/nrmicro2974
Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L (2014) The role of short-chain fatty acids in health and disease. Adv Immunol 121:91–119. https://doi.org/10.1016/b978-0-12-800100-4.00003-9
Tremaroli V, Bäckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242–249. https://doi.org/10.1038/nature11552
Tuleu C, Andrieux C, Cherbuy C, Darcy-Vrillon B, Duée PH, Chaumeil JC (2001) Colonic delivery of sodium butyrate via oral route: acrylic coating design of pellets and in vivo evaluation in rats. Methods Find Exp Clin Pharmacol 23:245–253. https://doi.org/10.1358/mf.2001.23.5.662119
Turroni F et al (2012) Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE 7:e36957. https://doi.org/10.1371/journal.pone.0036957
van de Wetering M et al (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241–250. https://doi.org/10.1016/s0092-8674(02)01014-0
Van den Abbeele P, Verstraete W, El Aidy S, Geirnaert A, Van de Wiele T (2013) Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome. Microb Biotechnol 6:335–340. https://doi.org/10.1111/1751-7915.12049
Van der Flier LG et al (2007) The intestinal Wnt/TCF signature. Gastroenterology 132:628–632. https://doi.org/10.1053/j.gastro.2006.08.039
Vivarelli S et al (2019) Gut microbiota and cancer: from pathogenesis to therapy. Cancers (basel) 11(1):38. https://doi.org/10.3390/cancers11010038
Wächtershäuser A, Stein J (2000) Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 39:164–171. https://doi.org/10.1007/s003940070020
Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D (2008) Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 19:587–593. https://doi.org/10.1016/j.jnutbio.2007.08.002
Walker AW, Duncan SH, Louis P, Flint HJ (2014) Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol 22:267–274. https://doi.org/10.1016/j.tim.2014.03.001
Wang H, Yang C, Doherty JR, Roush WR, Cleveland JL, Bannister TD (2014) Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors. J Med Chem 57:7317–7324. https://doi.org/10.1021/jm500640x
Wang L et al (2021) An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis. Bioeng Transl Med 6:e10219. https://doi.org/10.1002/btm2.10219
Weaver GA et al (1997) Acarbose enhances human colonic butyrate production. J Nutr 127:717–723. https://doi.org/10.1093/jn/127.5.717
Webster MT et al (2000) Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer 28:443–453
Wei D, Liu X, Yang ST (2013) Butyric acid production from sugarcane bagasse hydrolysate by Clostridium tyrobutyricum immobilized in a fibrous-bed bioreactor. Bioresour Technol 129:553–560. https://doi.org/10.1016/j.biortech.2012.11.065
Willems A, Amat-Marco M, Collins MD (1996) Phylogenetic analysis of Butyrivibrio strains reveals three distinct groups of species within the Clostridium subphylum of the gram-positive bacteria. Int J Syst Bacteriol 46:195–199. https://doi.org/10.1099/00207713-46-1-195
Wolever TM, Chiasson JL (2000) Acarbose raises serum butyrate in human subjects with impaired glucose tolerance. Br J Nutr 84:57–61
Xia C et al (2023) Human microbiomes in cancer development and therapy. MedComm (2020) 4:e221. https://doi.org/10.1002/mco2.221
Xiong LL, Mao ML, Shu QL (2022) A preliminary study on the diversity of butyrate-producing bacteria in response to the treatment of depression with Xiaoyaosan. Lett Appl Microbiol 75:844–856. https://doi.org/10.1111/lam.13737
Yan X et al (2015) Discovery and validation of potential bacterial biomarkers for lung cancer. Am J Cancer Res 5:3111–3122
Zhang C, Yang H, Yang F, Ma Y (2009) Current progress on butyric acid production by fermentation. Curr Microbiol 59:656–663. https://doi.org/10.1007/s00284-009-9491-y
Zhao L et al (2018) Sodium butyrate increases P-gp expression in lung cancer by upregulation of STAT3 and mRNA stabilization of ABCB1. Anticancer Drugs 29:227–233. https://doi.org/10.1097/cad.0000000000000588
Zigová J, Šturdík E (2000) Advances in biotechnological production of butyric acid. J Ind Microbiol Biotechnol 24:153–160. https://doi.org/10.1038/sj.jim.2900795
Funding
No funding is available for this review article.
Author information
Authors and Affiliations
Contributions
MRK: writing the original manuscript. SI: writing the original manuscript. SM: editing. MNM: editing. MAH: Review and editing. RM: review and editing. D-CY: review and editing. YJK: review and editing. JHS: review, supervision, and editing. DUY: review, editing, and supervision.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Additional information
Communicated by Yusuf Akhter.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Karim, M.R., Iqbal, S., Mohammad, S. et al. Butyrate’s (a short-chain fatty acid) microbial synthesis, absorption, and preventive roles against colorectal and lung cancer. Arch Microbiol 206, 137 (2024). https://doi.org/10.1007/s00203-024-03834-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00203-024-03834-7